69 Biotech Startups in London to Watch in 2023
London's Biotech sector is booming. This year’s list of the best 69 London Biotech startups is an eclectic mix of hyper-growth scaleups, small creative startups and everything in between.
Last update: September 08, 2023
Featured companies in Company
Featured
Biomedical research discovery tool.
-
Latest Funding
$60 Million · Series B
-
Employees
51 to 100
-
Investors
Marathon VC, Marathon VC, Pentech Ventures, Pentech Ventures, ICONIQ Growth, Index Ventures, Index Ventures, Index Ventures
-
Business Model
B2B, SAAS
-
Industries
Health Tech, AI, Biotech, Pharma
-
Locations
London
-
Contact
•••••@causaly.com
Unlock contact info
Featured
Preclinical stage treatment for geographic atrophy.
-
Latest Funding
$79 Million · Series A
-
Employees
1 to 10
-
Investors
Forbion Capital Partners, Gimv
-
Industries
Biotech
-
Locations
London
-
Contact
•••••@complementtx.com
Unlock contact info
Featured
Oophthalmic gene therapy company to treat blinding retinal illnesses.
-
Latest Funding
$120 Million · Series A
-
Employees
1 to 10
-
Investors
Syncona Partners LLP, Syncona Partners LLP
-
Industries
Health Tech, Biotech
-
Locations
London
-
Contact
•••••@beacontx.com
Unlock contact info
Full list of Biotech startups in London
Clinical trials platform.
-
Latest Funding
$18 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Valar Ventures, Creandum, Hambro Perks Ltd., Firstminute Capital, Seedcamp, Atomico, Calm/Storm Ventures
-
Contact
•••••@lindushealth.com
Unlock contact info
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
-
Latest Funding
$100 Million · Series B
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Kindred Capital, Octopus Ventures, Amadeus Capital
-
Contact
•••••@oribiotech.com
Unlock contact info
Quell Therapeutics is a cell therapy company
-
Latest Funding
$160 Million · Series B
-
Industries
Health Tech, Edtech, Biotech, Manufacturing
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Point72 Ventures, AlbionVC
-
Contact
•••••@quell-tx.com
Unlock contact info
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
-
Latest Funding
$35 Million · Series C
-
Industries
Agritech, Biotech, Deep Tech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Future Planet Capital
-
Contact
•••••@tropicbioscience.com
Unlock contact info
Platform to automate the clinical studies process.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
11.2 Capital, Delin Ventures, Playfair, AlbionVC
-
Contact
•••••@umed.io
Unlock contact info
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
-
Latest Funding
$68 Million · Series C
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Syncona Partners LLP, Sixth Element Capital, Boxer Capital, Invus, Forbion Capital Partners, AlbionVC
-
Contact
•••••@achillestx.com
Unlock contact info
Automata is a biotechnology company that provides workflow automation for the life sciences industry.
-
Latest Funding
$50 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Data and Analytics, Robotics, Manufacturing, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Latitude, Isomer Capital, Aldea VC, Local Globe, Octopus Ventures, Hummingbird Ventures, Firstminute Capital, HCVC, Entrepreneur First
-
Contact
•••••@automata.tech
Unlock contact info
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
-
Latest Funding
$50 Million · Series A
-
Industries
Health Tech, AI, Biotech, Data and Analytics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
General Catalyst, Khosla Ventures
-
Contact
•••••@charmtx.com
Unlock contact info
Quantum simulation platform for drug discovery.
-
Latest Funding
$2.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
ACF Investors, Ascension Ventures
-
Contact
•••••@kuano.ai
Unlock contact info
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.
-
Latest Funding
$25 Million
-
Industries
Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Kindred Capital, Atomico
-
Contact
•••••@labgeni.us
Unlock contact info
Cancer treatment predictor software.
-
Latest Funding
$14 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Octopus Ventures, Fly Ventures
-
Contact
•••••@pearbio.com
Unlock contact info
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
-
Latest Funding
$44 Million · Series C
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Andera Partners, Novo A/S
-
Contact
•••••@reviral.co.uk
Unlock contact info
Precision software for eye surgery.
-
Latest Funding
$8.1 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Redalpine
-
Contact
•••••@hypervisionsurgical.com
Unlock contact info
Precision therapeutics discovery platform.
-
Latest Funding
$6.2 Million · Seed
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures
-
Contact
•••••@multiomic.uk
Unlock contact info
Immuno-oncology company treats cancer with antibodies.
-
Latest Funding
$42 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Epidarex Capital, AlbionVC, Novartis Venture Fund
-
Contact
•••••@epsilogen.com
Unlock contact info
Protein discovery research and manufacturing.
-
Latest Funding
$20 Million · Series A
-
Industries
Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Investors
SYSTEMIQ
-
Contact
•••••@basecamp-research.com
Unlock contact info
At-home fertility treatment.
-
Latest Funding
$3.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
Octopus Ventures, QVentures, Calm/Storm Ventures
-
Contact
•••••@beafertility.com
Unlock contact info
Building the future of food, starting with dairy.
-
Latest Funding
$22 Million
-
Industries
Agritech, Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, B2C
-
Investors
CPT Capital, Entrepreneur First, Redalpine, Vorwerk Ventures
-
Contact
•••••@betterdairy.co.uk
Unlock contact info
Daye is a gynecological health company that creates products and services for vaginal treatment.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Index Ventures, Kindred Capital, Hambro Perks Ltd., Khosla Ventures
-
Contact
•••••@yourdaye.com
Unlock contact info
Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.
-
Latest Funding
$22 Million · Series A
-
Industries
Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
BACKED VC, CPT Capital
-
Contact
•••••@hoxtonfarms.com
Unlock contact info
Biomedical CloudOS data platform.
-
Latest Funding
$60 Million · Series B
-
Industries
Health Tech, Biotech, Data and Analytics, Business Intelligence
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B, SAAS
-
Investors
Eurazeo, Techstars, Connect Ventures, Tiny VC
-
Contact
•••••@lifebit.ai
Unlock contact info
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
-
Latest Funding
$6 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@myricxpharma.com
Unlock contact info
OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable.
-
Latest Funding
$8.2 Million
-
Industries
Fintech, Biotech, Proptech & Real Estate, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
Seventure Partners
-
Contact
•••••@opencell.bio
Unlock contact info
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Business Growth Fund, Parkwalk Advisors, Deepbridge Capital
-
Contact
•••••@pathfindermed.com
Unlock contact info
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
-
Latest Funding
$40 Million · Series A
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Bessemer Venture Partners
-
Contact
•••••@peptone.io
Unlock contact info
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
-
Latest Funding
$10 Million
-
Industries
Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Pi Campus, Y Combinator
-
Contact
•••••@sixfold.bio
Unlock contact info
Computer simulation to understand drug-bacteria interactions.
-
Latest Funding
$5 Million · Seed
-
Industries
Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Sofinnova Partners, Hoxton Ventures
-
Contact
•••••@biocortex.co.uk
Unlock contact info
Digital-twin simulator.
-
Latest Funding
$3.1 Million · Pre Seed
-
Industries
Biotech, Supply Chain & Logistics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Crane Venture Partners
-
Contact
•••••@quaisr.io
Unlock contact info
Developer of cutting-edge DNA techniques to monitor biodiversity.
-
Latest Funding
$13 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Investors
SYSTEMIQ, BNP Paribas, Triple Point Ventures, Green Angel Ventures
-
Contact
•••••@naturemetrics.co.uk
Unlock contact info
Gene and cell therapy manufacturing.
-
Latest Funding
$66 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@ascend-gctx.com
Unlock contact info
Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.
-
Latest Funding
$11 Million · Seed
-
Industries
Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Lowercarbon Capital, Amadeus Capital, BoxGroup, Ascension Ventures, Plug and Play Spain
-
Contact
•••••@epochbiodesign.com
Unlock contact info
FabricNano is a cell-free biomanufacturing company that develops biocatalysts to unlock the future of biochemistry.
-
Latest Funding
$13 Million · Series A
-
Industries
Biotech, Energy & Nuclear, Robotics, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, BACKED VC, Atomico, Entrepreneur First
-
Contact
•••••@fabricnano.com
Unlock contact info
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
-
Latest Funding
$68 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Forbion Capital Partners
-
Contact
•••••@pheontx.com
Unlock contact info
Developer of innovative treatment for muscle wasting disorders.
-
Latest Funding
$6.1 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Mankind Pharma
-
Contact
•••••@actimedtherapeutics.com
Unlock contact info
Immunotherapy for the treatment of cancer.
-
Latest Funding
$1.5 Million · Seed
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Cancer Research Horizons, UK Innovation & Science Seed Fund
-
Contact
•••••@nk-io.com
Unlock contact info
Arborea is industrialising photosynthesis to expand the world’s food supply
-
Latest Funding
$4.1 Million · Seed
-
Industries
Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Business Growth Fund
-
Contact
•••••@arborea.io
Unlock contact info
Baseimmune is a biotech startup founded to create the next generation of vaccines.
-
Latest Funding
$4.8 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Hoxton Ventures, Cherry Ventures, Creator Fund, Maki.vc
-
Contact
•••••@baseimmune.co.uk
Unlock contact info
dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA.
-
Latest Funding
$60 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@dnanudge.com
Unlock contact info
Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.
-
Latest Funding
$4.1 Million
-
Industries
Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Octopus Ventures, Metaplanet Holdings, Ascension Ventures
-
Contact
•••••@foodsteps.earth
Unlock contact info
Gardin develops optical phenotyping technology and analytics to optimise food production.
-
Latest Funding
$11 Million · Seed
-
Industries
Agritech, Foodtech, Biotech, Data and Analytics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Molten Ventures, MMC Ventures, Seedcamp
-
Contact
•••••@gardin.co.uk
Unlock contact info
Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water
-
Latest Funding
$3.6 Million · Seed
-
Industries
Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Kindred Capital, Verve Ventures
-
Contact
•••••@puraffinity.com
Unlock contact info
Shellworks is a biotech startup on a mission to make plastic waste a thing of the past.
-
Industries
Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing, Supply Chain & Logistics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Local Globe, Atomico, BoxGroup, Ascension Ventures
-
Contact
•••••@theshellworks.com
Unlock contact info
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.
-
Latest Funding
$35 Million · Series C
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Sofinnova Partners
-
Contact
•••••@synthace.com
Unlock contact info
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
-
Latest Funding
$52 Million
-
Industries
Health Tech, Hardware, Biotech
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@pulmocide.com
Unlock contact info
User-owned genomics database platform.
-
Latest Funding
$20 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
GEM Digital
-
Contact
•••••@genomes.io
Unlock contact info
Portfolio of pharmaceutical research and discovery.
-
Latest Funding
$230 Million · Series C
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Patient Square Capital, Rock Springs Capital
-
Contact
•••••@apollotherapeutics.com
Unlock contact info
Immunotherapy for bladder cancer.
-
Latest Funding
$30 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@prokarium.com
Unlock contact info
Patent-protected anti-inflammatory painkiller.
-
Latest Funding
$6.3 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
ITV AdVentures
-
Contact
•••••@flarin.co.uk
Unlock contact info
One lab management platform that brings people, equipment and data together - no matter where they are.
-
Latest Funding
$3.5 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Forward Partners
-
Contact
•••••@clustermarket.com
Unlock contact info
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.
-
Latest Funding
$1.9 Million · Pre Seed
-
Industries
Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Atomico, Entrepreneur First
-
Contact
•••••@exogene.co.uk
Unlock contact info
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.
-
Latest Funding
$15 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Genetics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@minatx.com
Unlock contact info
Sequential Skin is improving human health with the world's first skin microbiome test for consumers and companies.
-
Latest Funding
$1.7 Million · Seed
-
Industries
Health Tech, Fashion, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Metaplanet Holdings
-
Contact
•••••@sequentialskin.com
Unlock contact info
AI-powered bioengineering platform to develop eco-friendly substitutes to every day materials.
-
Latest Funding
$3.7 Million · Seed
-
Industries
Biotech, Machine Learning
-
Locations
London
-
Employees
1 to 10
-
Investors
Seedcamp, Creative UK, Project A Ventures
-
Contact
•••••@twig.bio
Unlock contact info
Animal-free cell production company.
-
Latest Funding
$9.7 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@multus.bio
Unlock contact info
Supply chain platfrom for pharma.
-
Latest Funding
$6.5 Million · Series A
-
Industries
Biotech, Pharma, Supply Chain & Logistics
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@veratrak.com
Unlock contact info
Bluezone Insurance offers personalized, same-day life cover for people with chronic conditions, like type 2 diabetes and heart diseases.
-
Latest Funding
$1.9 Million · Seed
-
Industries
Health Tech, Fintech, Biotech, Deep Tech, Insuretech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
Insurtech Gateway, Portfolio Ventures
-
Contact
•••••@bluezoneinsurance.co.uk
Unlock contact info
Concert Bio helps businesses create optimal microbial communities.
-
Latest Funding
$1.7 Million · Pre Seed
-
Industries
Agritech, Biotech, Business Intelligence
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
Nucleus Capital
-
Contact
•••••@concert.bio
Unlock contact info
Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.
-
Latest Funding
$1 Million
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Y Combinator
-
Contact
•••••@digistain.co.uk
Unlock contact info
LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery.
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
Hoxton Ventures, Y Combinator
-
Contact
•••••@liliumx.com
Unlock contact info
Neucruit is transforming the efficiency, transparency and diversity of clinical trials
-
Latest Funding
$1 Million · Seed
-
Industries
Health Tech, Biotech, Hiring and Recruitement, Data and Analytics, Community & Lifestyle, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Atomico, Nina Capital
-
Contact
•••••@neucruit.com
Unlock contact info
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Y Combinator
-
Contact
•••••@nuntiustx.com
Unlock contact info
Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc.
-
Industries
Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Y Combinator, Katapult Accelerator
-
Contact
•••••@syronahealth.com
Unlock contact info
Emm is developing the next generation of bio-wearables for better healthcare
-
Latest Funding
$1.1 Million
-
Industries
Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Innovate UK
-
Contact
•••••@emm.co
Unlock contact info
Itero creates profitable waste management solutions.
-
Latest Funding
$6.1 Million
-
Industries
Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@itero-tech.com
Unlock contact info
Polymateria is a London-based startup advancing science to help nature deal with plastic pollution.
-
Latest Funding
$19 Million
-
Industries
Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@polymateria.com
Unlock contact info
Zedsen provides biosensors that create a 3-Dimensional electrical field and gathers biological signals within a human body.
-
Latest Funding
$12 Million · Series B
-
Industries
Health Tech, Hardware, Biotech, Manufacturing, Community & Lifestyle
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@zedsen.com
Unlock contact info